The Centre of Excellence in Severe Asthma hosted Professor Peter Gibson and Associate Professor Nathan Bartlett for a webinar on “COVID-19 and Severe Asthma: Recommendations and looking toward treatment and prevention” on 28th May 2020.
Presentation Summary:
Professor Peter Gibson introduced the “Clinical Recommendations for COVID-19 in Severe Asthma” developed by the Centre of Excellence in Severe Asthma. These recommendations are available here, and the associated infographics can be found at the severe asthma toolkit.
Key Points Covered:
- COVID-19: The virus, transmission, symptoms and impact.
- Severe Asthma and COVID-19, including recommendations for severe asthma management, attack management and isolation.
- Accessing and administering monoclonal antibody therapies during the COVID-19 pandemic.
- The safety of drugs and devices commonly used in severe asthma
- Wellbeing during the pandemic
- Asthma and COVID-19 risk
About Professor Peter Gibson
Professor Gibson is a world leading respiratory physician and clinical researcher. Professor Gibson works at the clinical interface as well as conducting world leading research into improving treatment regimens and management strategies for asthma and airway disease.
Associate Professor Nathan Bartlett presented on “I want my life back… Looking toward treatment and prevention of COVID-19”
Key Points Covered:
- Anti-viral approaches to COVID-19: What to target.
- Direct anti-viral therapies
- Nucleoside/tide analogues
- Viral enzyme inhibitors
- Indirect anti-viral therapies
- Viral receptor blockade
- Growth factor receptors
- Macrolide antibiotics
- Hydroxychloroquine
- Toll-like receptors and TLR2 agonist
- Direct anti-viral therapies
- Effective drug delivery
- Polymer Lipid Hybrid Nano-particles
- Vaccinations – long term goal for wide spread prevention
About Associate Professor Nathan Bartlett
Associate Professor Bartlett is the head of the Viral Immunology and Respiratory Disease group and is based at the Hunter Medical Research Institute. Associate Professor Bartlett is currently exploring novel therapies and treatments to fight COVID-19. His team is exploring a range of anti-viral options for this virus, partnering with other researchers to explore different methods to fight the virus.
